Sunshine Lake Pharma Co., Ltd.
Works in Genetic & rare · GI & liver · Hematology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Psychiatry · Renal & urogenital · Respiratory · Women's health
Sunshine Lake Pharma Co., Ltd. is a clinical trial sponsor. It has 13 active clinical trials with 2,896 planned participants, across 12 therapeutic areas. Since 2021 it has completed 44 trials and stopped 8 early.
Trial track record · since 2021
Pipeline · 13 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Sunshine Lake Pharma Co., Ltd
Sunshine Lake Pharma Co., Ltd is lead sponsor of 13 active clinical trials on ClinicalTrials.gov, with 2,896 planned participants, in Genetic & rare, GI & liver, Hematology, Infectious disease and other areas. Since 2021 it has completed 44 trials and stopped 8 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Sunshine Lake Pharma Co., Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-14.
Approve Suite is not affiliated with Sunshine Lake Pharma Co., Ltd.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.